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ABSTRACT
The present study compared the anti-oxidative ability of intact cells and intracellular extracts of two lactic acid bacterial
strains, Bifidobacterium longum and Lactobacillus delbrueckii ssp. bulgaricus. Results showed that both intact cells and intracellular extracts of 109 cells of B. longum and L. delbrueckii ssp. bulgaricus had the ability to scavengeα-diphenyl-β-picrylhydrazyl
(DPPH) free radical by 70.4-75.1%, to inhibit liposome peroxidation by 25-31%, and to decrease significantly the malondialdehyde
(MDA) production in Intestine 407 cells. The effect of intact cells and intracellular extracts of these two bacterial strains on the
oxidation of low density lipoprotein (LDL) isolated from cerebrovascular accident (CVA) patients and healthy subjects was also
compared. Oxidation of LDL was monitored by measuring the lag time for the formation of conjugated dienes in isolated LDL
particles. When LDL was treated respectively with 109 intact cells of B. longum and L. delbrueckii ssp. bulgaricus, the lag time
of oxidation of LDL was prolonged significantly. The extent of inhibition was greater on LDL isolated from healthy subjects than
from CVA patients. When LDL from either CVA patients or healthy subjects was treated with intracellular extracts of 109 cells of
B. longum and L. delbrueckii ssp. bulgaricus, respectively, the copper-mediated oxidation was extensively inhibited with a lag time
exceeding 180 min. Results from this study show a greater inhibitory effect on LDL oxidation exerted by the intracellular extract
than the intact cells, suggesting the presence of effective inhibitory factors in the intracellular extract.
Key words: lactic acid bacteria, antioxidation, LDL oxidation, intact cells, intracellular extracts

INTRODUCTION
In last two decades, it has become clear that dietary
strategy is effective in managing many chronic diseases,
such as cardiovascular diseases. Lines of evidence suggested that intake of foods rich in natural antioxidants can
reduce the risk of atheroscleorosis(1-4). Lactic acid bacteria, which have been traditionally used in various fermented foods, are important members of intestinal microflora.
They play vital roles in the maintenance of the intestinal
microbial ecosystem. The potential health attributes of
lactic acid bacteria include the control of gastrointestinal
infections, improvement of lactose intolerance, reduction of
serum cholesterol, stimulation of immunomodulation, anti* Author for correspondence. Tel: +886-4-2284-0385 ext. 2208;
Fax: +886-4-2287-6211; E-mail: mylin@dragon.nchu.edu.tw

carcinogenicity, and longevity(5-9). Recent studies have also
shown that various strains of lactic acid bacteria exhibit
antioxidative activity both in vivo and in vitro(3,8,10-14).
The objective of this study was to compare the antioxidative ability of two strains of lactic acid bacteria,
Bifidobacterium longum and Lactobacillus delbrueckii
ssp. bulgaricus as intact cells or the intracellular extracts.
The antioxidative ability was measured based on the
scavenging of α,α-diphenyl-β-picrylhydrazyl (DPPH)
radicals and the inhibition of lipid peroxidation of two
model systems, a liposome system and a cell membrane
system of Intestine 407 cells. The inhibitory effects of
these two strains of lactic acid bacteria on the oxidation
of LDL isolated respectively from cerebrovascular accident (CVA) patients and healthy subjects have also been
evaluated.
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MATERIALS AND METHODS

Isolation and identification of B. longum MYL2 and
L. delbrueckii ssp. bulgaricus MYL6 from new born
infants were performed in the Microbiology Laboratory in Department of Food Science and Biotechnology
of National Chung Hsing University, Taichung, Taiwan.
These bacteria were grown at 37°C in MRS (Difco Laboratories, Detroit, MI, USA). Both strains were serially
transferred at least three times prior to use.

of lactic acid bacteria (or α-tocopherol for the control)
were mixed and incubated at 37°C in a water bath. The
lipid peroxidation was assessed by the thiobarbituric acid
(TBA) assay as described by Decker and Faraji(17). After
12 hr of incubation, the reaction solution was mixed with 1
mL of trichloroacetic acid (TCA, 2.8%), 1 mL of 1% TBA,
and 1 mL of 0.5 mM butylated hydroxytoluene (BHT). The
mixture was incubated at 100°C for 30 min. After cooling, methanol was added for extraction. The absorbance
of the upper phase was measured at 532 nm. The level of
inhibition (%) on lipid peroxidation was calculated as: [1A532(sample) /A532(control)] × 100%.

II. Preparation of Intact Cells and Intracellular Extracts

V. Cell Culture

Cells of B. longum and L. delbrueckii ssp. bulgaricus were harvested by centrifugation at 6,000 g for 10
min after 18 h of incubation at 37°C. For the preparation of intact cells, cells were washed three times with
phosphate buffer solution (PBS; 0.85% NaCl, 2.86 mM
KCl, 10 mM Na 2HPO 4, and 1.76 mM KH 2PO 4, pH=7.4)
and resuspended in PBS. For preparation of intracellular
extracts, cell pellets were washed twice with deionized
water and resuspended in deionized water followed by
ultrasonic disruption in five 1-min intervals in an ice bath
(setting = 4; Sonicator XL-2020; Heat System, Farmingdale, NY, USA). Cell debris was removed by centrifugation at 7,800 g for 10 min, and the resulting supernatant was used as the intracellular extract. The total cell
numbers were adjusted to 109 cfu/mL for the preparation
of both intact cells and intracellular extracts.

Intestine 407 (BCRC 60022) cells were purchased
from the Bioresource Collection and Research Center
(BCRC, Hsinchu, Taiwan). Cells were grown in basal
Eagle medium (BEM) supplemented with Earle’s BSS
and 15% fetal bovine serum (Gibco BRL, Life Technologies, Grand Island, NY, USA) and incubated in a humidified atmosphere of air/CO2 (95:5, v/v) at 37°C. Conf luent
cells were washed twice with PBS. Trypsin-EDTA (1
mL, 0.05% trypsin and 0.53 mM EDTA) was added and
left at room temperature for 5 min. BEM (2 mL) was
then added and cells were harvested by centrifugation at
600 g for 5 min.

I. Lactic Acid Bacterial Strains

III. Determination of α,α-Diphenyl-β-Picrylhydrazyl (DPPH)
Radical
The ability to scavenge DPPH radicals by B. longum
and L. delbrueckii ssp. bulgaricus was assessed by a
modified method of Takahashi et al.(15). Eight tenths
of a milliliter of intact cells or intracellular extract and
1 mL of freshly prepared DPPH solution (0.2 mM in
methanol) were mixed and allowed to react for 30 min
at room temperature. Blank samples contained either
PBS or deionized water. The level of scavenged DPPH
was then monitored by the decrease in absorbance at 517
nm. The scavenging ability was defined as follows: [1A 517(sample)/A 517(blank control)] × 100%.
IV. Inhibition of Lipid Peroxidation in Liposomes
Liposome suspension was prepared by following the
protocol of Ansari et al.(16). Phosphatidyl choline in ethanol was suspended in PBS (pH=7.4), followed by ultrasonic
disruption (setting = 4; Sonicator XL-2020; Heat System,
Farmingdale, NY, USA). Sonication was then performed
on three 4-second intervals in an ice bath. One milliliter of
liposomal suspension, 100 μL PBS buffer, 1mM FeCl3, 200
μL ascorbic acid, and intact cells or intracellular extracts

VI. Measurement of Malondialdehyde (MDA)
MDA was chosen as the indicator for the secondary
product of lipid peroxidation. The inhibitory effect of B.
longum and L. delbrueckii ssp. bulgaricus on lipid peroxidation in Intestine 407 cells was determined by thiobarbituric acid reactive substances (TBARS) assay(17). The
procedure for the quantitation of MDA was the same as
TBA method mentioned above. For liposomal lipid peroxidation, BEM (2 mL) was first inoculated with 1 × 105
Intestine 407 viable cells. The intact cells or intracellular
extracts of two bacterial strains were then added to the
mixture and incubated at 37°C for 4 hr. Hydrogen peroxide (final conc. 0.8 mM) was added as a pro-oxidant. One
milliliter of supernatant, 2.8% TCA, and 0.7% TBA were
added and mixed. The mixture was allowed to react at
100°C for 10 min. The lipid peroxidation product was
extracted with 1-butanol. The absorbance at 532 nm
of the upper phase obtained by centrifugation was then
determined.
VII. Preparation of Low-Density Lipoprotein (LDL) Fraction from Cerebrovascular Accident (CVA) Patients and
Healthy Subjects
CVA patients (19 women and 11 men, age ranging
from 54 to 76 years old) were recruited from a special
clinic in Chung Shan Medical University Hospital, Taichung, Taiwan. Twenty four healthy subjects (12 women
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and 12 men, age ranging from 53 to 73 years old) recruited through advertisement were selected as the control of
this study. All procedures were in accordance with the
guidelines of the Human Subjects Review Committee of
the Chung Shan Medical University. All participants have
also provided the informed consent.
Overnight fasted blood sample (15 mL) from each
subject was drawn into a test tube containing EDTA.
Blood was centrifuged at 1,000 g for 15 min at 4°C to
separate plasma and red blood cells. An aliquot of plasma
was used to prepare LDL fraction, and the remaining
plasma was stored at -80°C until analyzed.
LDL fraction from plasma was prepared by continuous density gradient ultracentrifugation at 180,000 g for 16
h at 4°C. One mL of LDL fraction was aspirated after twice
ultracentrifugation and dialyzed in PBS (pH=7.4) at 4°C for
over 16 h to eliminate salt, EDTA and albumin right prior
to measurement of LDL oxidation. The protein concentration of LDL was determined by the method of Lowry et
al.(18), using bovine serum albumin as the standard. In all
experiments, the LDL fractions were diluted with PBS to
give a final protein concentration of 200 μg/mL.

standard curves constructed with the internal standards
mentioned previously. Total plasma lipid concentration
was determined and used to adjust the value of α-tocopherol, which is expressed as μg/mg total lipid.

VIII. Determination of Ascorbic Acid in Plasma

XI. Measurement of LDL Oxidation

The concentration of ascorbic acid in plasma was
determined by the method of Kyaw(19). Two milliliters of
color reagent was added slowly to 2.0 mL fresh plasma in a
centrifuge tube. The color reagent was prepared by mixing
0.75 M sodium tungstate, 0.75 M disodium hydrogen phosphate and 6.25% sulfuric acid (v/v). After thoroughly
mixing, the reaction mixture was allowed to stand at room
temperature for 30 min and then centrifuged at 6,000 g for
15 min. The blue color supernatant was transferred to a
test tube with a pipette without disturbing the precipitate.
Absorbance at 700 nm was measured against a reagent
blank. For each set of analyses, a standard and a reagent
blank were run in parallel throughout the procedure.

LDL oxidation was measured by a modified method
of Abuja and Albertini(22). Oxidation was initiated by
adding 0.5 mM CuSO 4 to a spectrophotometer cuvette
containing 1.2 mL LDL (200 μg/mL protein) in PBS
buffer with or without either intact cells or intracellular extracts of lactic acid bacteria. The kinetics of LDL
oxidation was monitored by reading the absorbance (234
nm) every 5 min for 3 hr at 37°C in a Hitachi U-3000
spectrophotometer. The start of the propagation phase
was determined by the intersection of tangential lines
drawn through the flat lag or induction phase and the
steeply sloping propagation phase.

IX. Determination of α-Tocopherol in Plasma
The concentration of α-tocopherol in plasma was
analyzed by HPLC method according to the protocol of
Catignani and Bieri(20). An aliquot of 50 μL of internal
standards (52.5 mg/L α-tocopheryl acetate in ethanol)
and 100 μL of plasma were mixed by vortexing for 1 min.
Two-tenths mL of n-hexane was then added and mixed for
another 1 min to extract the lipid. The organic and aqueous phases were separated by centrifugation at 800 g for
2 min. The n-hexane layer was withdrawn and evaporated under a nitrogen stream. The residue was re-dissolved
in 50 μL of HPLC-grade methanol and an aliquot of 20
μL was injected into an HPLC system for chromatographic analysis of α-tocopherol at ambient temperature. The mobile phase was 98% HPLC grade methanol
and the flow rate was 1.2 mL/min. Peak area ratios of the
samples were converted to α-tocopherol (μg) by using the

X. Thiobarbituric Acid Reactive Substances (TBARS) Assay
Lipid peroxidation in plasma and red blood cell was
measured by TBARS by a modified method, as described
by Fraga and co-workers (21). Briefly, plasma and red
blood cell (RBC) samples were homogenized in 50 mM
potassium phosphate buffer (pH 7.4). To the plasma
or RBC homogenate were added 0.5 mL of 3% sodium
dodecyl sulfate, 2 mL of 0.1 N HCl, 0.3 mL of 10% phosphotungstic acid, and 1 mL of 0.7% TBA. The mixture
was heated in a boiling water bath for 30 minutes, and
TBARS were extracted into 5 mL of 1-butanol. After
centrifugation, the fluorescence of the butanol layer was
measured at 515 nm excitation and 555 nm emission in a
fluorescence spectrophotometer (model F-4500, Hitachi,
Tokyo, Japan). A malondialdehyde standard curve was
also made using 1,1,3,3-tetramethoxypropane.

XII. Statistical Analysis
The experiment was conducted using a completely
random design. Data were analyzed using analysis of variance (ANOVA). Student’s t test was applied to test differences between healthy and CVA patients. Ducan’s test was
applied to test differences between treatments. A significant level was detected at 0.05 probability level. All statistical analyses of data were performed using SAS software.

RESULTS
I. Scavenging of α,α-Diphenyl-β-Picrylhydrazyl (DPPH)
Radical
Results of scavenging of DPPH by intact cells and
intracellular extracts of 109 cells of B. longum and L.
delbrueckii ssp. bulgaricus are shown in Table 1. Both B.
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longum and L. delbrueckii subsp. bulgaricus had excellent DPPH scavenging ability. Intact cells and intracellular extracts of 109 cells of B. longum and L. delbrueckii
ssp. bulgaricus showed the ability to scavenge 70.4-75.1%
of DPPH free radical. There was no significant difference
between the two bacterial strains and between the intact
cells and the intracellular extracts.
II. Inhibition of Liposome Peroxidation
The effect of 109 cells of B. longum and L. delbrueckii

Table 1. Scavenging effect of B. longum and L. delbrueckii ssp. bulgaricus on DPPH free radicals*
Strain

DPPH scavenged (%)

B. longum
Intact cells

71.3 ± 3.4

Intracellular extract

72.6 ± 3.8

L. delbrueckii ssp. bulgaricus
Intact cells

70.4 ± 5.2

Intracellular extract

75.1 ± 4.9

* Scavenging ability of 1 mL of intact cells or intracellular extracts
of B. longum and L. delbrueckii ssp. bulgaricus. Total cell
numbers were adjusted to 109 CFU/mL for the preparation of intact
cells and intracellular extracts. Scavenging ability is expressed
as the percentage of DPPH scavenged, which was defined as:
[1-A 517(sample)/A 517(blank)] × 100%. Data are means ± SD of
triplicate experiments.

Table 2. Inhibition of liposome lipid peroxidation by B. longum and
L. delbrueckii ssp. Bulgaricus*
Treatment

Intracellular extract

III. Inhibition of Cell Membrane Lipid Peroxidation
In this study, the cell membrane of Intestine 407
cells was used as the source of biological lipid and
H 2O2 was added as the pro-oxidant. Results in Table 3
show that the level of MDA, a lipid peroxidation product used as an index of lipid peroxidation, significantly
decreased when cell membrane was treated with intact
cells of either lactic acid bacterial strain. There was no
difference between two strains. The MDA levels were
also suppressed by the intracellular extracts of either
lactic acid bacterial strain. However, the inhibitory effect
was significantly enhanced when Intestine 407 cells were
treated with the intracellular extract from the B. longum
or L. delbrueckii ssp. bulgaricus ( p < 0.05).
IV. Antioxidant Vitamins and TBARS
As shown in Table 4, although the levels of lipidsoluble antioxidant α-tocopherol were not different
between two groups, the levels of the water-soluble anti-

Table 3. Inhibitory effect of B. longum and L. delbrueckii ssp. bulgaricus on lipid peroxidation of Intestine 407 cellsa
Malondialdehyde
(µM) produced

% inhibition

4.9 ± 0.5 a

－

Intact cells

3.5 ± 0.5 b

28.6

Intracellular extract

2.5 ± 0.5 c

49.0

Intact cells

3.7 ± 0.2 b

24.5

Intracellular extract

2.9 ± 0.5 c

40.8

Inhibition rate (%)
Controlb

B. longum
Intact cells

subsp. bulgaricus (as intact cells or intracellular extracts)
on liposome lipid peroxidation is presented in Table 2.
Results showed that both strains were able to protect liposome lipid from oxidation. The inhibition rate ranged from
25 to 31%, which was equivalent to approximately 4 mg (1
mg = 1.49 I.U.) of α-tocopherol. There was no significant
difference between two bacterial strains and between the
intact cells and the intracellular extracts.

30.8 ± 3.2 c
30.2 ± 2.9 c

L. delbrueckii ssp. bulgaricus
Intact cells

26.5 ± 4.9 c

Intracellular extract

25.4 ± 4.5 c

Strain
B. longum

L. delbrueckii ssp. bulgaricus

Vitamin E
4 mg

34.4 ± 3.6 c

8 mg

44.2 ± 4.1 b

16 mg

53.2 ± 2.8 a

* Lipid peroxidation inhibition of 1 mL of intact cells or intracellular cell-free extracts of B. longum and L. delbrueckii ssp. bulgaricus
or vitamin E. Total cell numbers were adjusted to 109 CFU/mL for
the preparation of intact cells and intracellular extracts.
For vitamin E, the recommended dietary allowance is 15 mg (1 mg
= 1.49 I.U.). Values with different letters are significantly different
(p < 0.05). Data are means ± SD of triplicate experiments.

a

 ipid peroxidation inhibition of 1 mL of intact cells or intracellular
L
cell-free extracts of B. longum and L. delbrueckii ssp. bulgaricus.
Total cell numbers were adjusted to 109 CFU/mL for the preparation of intact cells and intracellular extracts. Values with different
letters are significantly different (p < 0.05). Data are means ± SD
of triplicate experiments.
b
Control was 0.8 mM H2O2 without treating with lactic acid
bacteria.
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oxidant ascorbic acid were significantly lower in patients
with CVA. The levels of TBARS in both red blood cells
and plasma were significantly higher in CVA patients
when compared to those from healthy subjects ( p < 0.05).
V. LDL Oxidation
Table 5 shows the mean oxidation lag time (min) of
LDL isolated from CVA patients and healthy subjects
were 58.3 ± 19.6 min and 62.3 ± 22.9 min, respectively.
No significant difference was found between these two
groups. When treated respectively with intact cells of
B. longum and L. delbrueckii ssp. bulgaricus, the oxidation lag time of LDL isolated from CVA patients was
increased by 44% and 56%, respectively, whereas that
from healthy subjects was increased by 53% and 65%,
respectively. When LDL was treated respectively with
intracellular extracts of 109 cells of B. longum and L.
delbrueckii ssp. bulgaricus, the copper-mediated oxidation was significantly suppressed with the mean oxidation lag time exceeding 180 min for both CVA patients
and healthy subjects (Figure 1).

DISCUSSIONS
Lactic acid bacteria have long been known to be
probiotic for maintenance of intestinal microbial ecosystem and promotion of host health. B. longum and L.
delbrueckii ssp. bulgaricus make up a significant part
of the natural microflora of the human intestinal tract.
They create a healthy balance between beneficial and
potentially harmful microorganisms in the gut ecosystem
when they are present in sufficient numbers. The use of
these cultures in fermented foods or as dietary supplements is desirable for their potential probiotic effects.
These cultures may or may not survive in the intestine
after they are consumed. The major factors determining survival of these bacteria include characteristics of
the strains (e.g., acid and bile tolerance), composition
of food ingested, and competition of microflora in the
intestine. Strains isolated from human sources are likely
to have a better chance to survive and even colonize in
the intestine. However, certain numbers of these bacteria
are lysed and their intracellular extracts released into the
gut. Therefore, it is of interest to compare the antioxidative ability of intact cells and intracellular extracts of B.
longum and L. delbrueckii ssp. bulgaricus.

Table 4. Plasma antioxidant vitamins and lipid peroxidation products in healthy subjects and CVA patientsa
Healthy subjects (n = 24)

CVA patients (n = 30)

Ascorbic acid (mg/dL)

2.3 ± 1.0 a

1.1 ± 0.6 b

Vitamin E (µg/mg lipid)

2.6 ± 1.1 a

2.4 ± 1.3 a

LDL-vitamin E

6.6 ± 1.7 a

7.2 ± 1.9 a

Red blood cell-TBARSb (nM/mL)

9.5 ± 1.4 b

12.2 ± 1.3 a

Plasma-TBARS (nM/mL)

5.7 ± 0.9 b

8.6 ± 0.8 a

(µM/mg LDL protein)

a

Student’s t test was applied to test differences between healthy and CVA patients. Data in the same row with different letters are significantly different at p < 0.05.
b
TBARS: thiobarbituric acid reactive substances.

Table 5. Effect of intact cells of B. longum and L. delbrueckii ssp. bulgaricus on the oxidation lag time (min) of LDL from healthy subjects
and CVA patientsa
Healthy subjects (n = 24)

CVA patients (n = 30)

Placebo

62.3 ± 22.9 a

58.3 ± 19.6 a

Intact cells of

95.6 ± 24.3 bc

83.9 ± 27.3 bc

B. longum
Intact cells of

(↑53%)

b

(↑44%)

102.8 ± 19.9 c

91.0 ± 28.1 bc

(↑65%)

(↑56%)

L. delbrueckii ssp. bulgaricus
a

b

Data with different letters are significantly different at p < 0.05.
Percentage increase of the oxidation lag time of LDL
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Figure 1. The inhibitory effect of B. longum and L. delbrueckii ssp.
bulgaricus on oxidation of LDL isolated from the blood of healthy
subjects (A) and CVA patients (B) (, control; , treated with intact
cells of B. longum; , treated with intact cells of L. delbrueckii ssp.
bulgaricus; ×, treated with intracellular extract of B. longum; ,
treated with intracellular extract of L. delbrueckii ssp. bulgaricus).

In this study, the free radical scavenging ability
of two bacterial strains was first compared. As shown in
Table 1, no significant differences in scavenging ability
were found between two bacterial strains either as intact
cells or intracellular extracts. This finding suggests that
levels of the antioxidative factor contributed by either
strain were comparable.
In our second study, the antioxidative effect of
two bacterial strains was examined using the liposomal
lipid system, as peroxidation of liposomal lipids is often
utilized as a simple model system to evaluate the lipid
peroxidation in biological cell membrane (16,23). Results in
Table 2 indicate that both bacterial strains either as intact
cells or as intracellular extracts inhibited significantly the
Fe +2/H 2O2-induced peroxidation in liposomes. It again
suggests that level of the antioxidant factor contributed
by either strain was comparable.
In the third study, Intestinal 407 cells were used as
the intestinal cell membrane model system to investigate
the inhibitory effect exerted by these two strains on the
H 2O2-induced oxidative damage. Results in Table 3 show
that the lipid peroxidation (measured by the formation
of MDA) decreased in the presence of intact cells and
intracellular extracts of these two strains, indicating that

both intact cells and intracellular cell-free extracts of B.
longum and L. delbrueckii ssp. bulgaricus were effective in inhibiting the H 2O2-induced oxidative damage.
However, the intracellular extracts, in comparison with
the intact cells, exhibited a greater inhibitory effect. It
suggests that the level of antioxidant factor in the intracellular extracts was greater than that released in the
medium by the intact cells.
The inhibitory effect of these two strains was also
examined, either as intact cells or intracellular extracts
on oxidation of LDL isolated from patients with cardiovascular disease and from healthy subjects. Results in
the preliminary study have demonstrated a similar lag
time of LDL oxidation between LDL isolated from CVA
and those from the healthy subjects. However, the lag
time of LDL oxidation was significantly prolonged in
the presence of these two strains of bacteria, more so in
LDL isolated from the healthy subjects than those from
the CVA. Since the LDL-α-tocopherol contents were not
significantly different between CVA and healthy subjects,
the difference in inhibitory capability could not be attributed to different α-tocopherol level in LDL. Results in
Figure 1 also show when LDL was treated with the intracellular extracts, nearly all the oxidation of LDL was
inhibited. The findings suggest that the availability of the
antioxidative factor was greater when cells were disrupted
than intact. A similar finding has previously been reported by Saide and Gilliland (12) that intracellular extracts of
lactobacilli possessed markedly increased antioxidative
activity than intact cells. Since it has been indicated that
Lactococcus expresses activity of antioxidative enzyme
superoxide dismutase (SOD)(24), it is possible that the
significant increase in inhibitory activity of the intracellular extracts could be due to the greater accessibility of
antioxidative enzymes to the oxidant substractes.
The antioxidative effects were found for the intact
cells and intracellular extracts of lactic acid bacteria in
vitro. According to our previous study(25), the intracellular extracts of lactic acid bacteria have metal ion chelating ability, reactive oxygen species scavenging ability
and reduction activity. Although conditions in the gastrointestinal tract are very complicated, the study of Kaizu
et al.(10) demonstrated that the intracellular extract is
also antioxidative in vivo. In addition, Kaizu et al. have
demonstrated that hemolysis of red blood cells was inhibited in rats which were administered with the intracellular extracts of Lactobacillus sp. SBT 2028. Rats deficient in α-tocopherol, a well-known natural antioxidant,
were used for the experiments. The results provided
evidence that the intracellular extract is antioxidative
and, therefore, improved the α-tocopherol deficiency
status. It is reasonable to expect a significant number of
lactic acid bacteria are lysed and release their intracellular antioxidative constituents during transit through the
gastrointestinal tract (26,27). We strongly recommend that
consumers consume lactic acid bacteria fermented products containing live probiotic bacteria. However, these
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probiotic bacteria do not necessarily have to be acid or
bile resistant to stay alive in gastrointestinal tract to be
probiotic, i.e. antioxidative in this study. Intact cells of
lactic acid bacteria were indeed found possessing antioxidative ability in vitro (28). Nevertheless, using the intact
cells as the delivery vehicles passing through the gastrointestinal tract, the intracellular constituents released
from the lactic acid bacteria in gastrointestinal tract can
be also antioxidative. Consumption of lactic acid bacteria
containing foods or supplements may be recommended
as healthy. It is well established that a wide variety of
oxygen-centered free radicals and other reactive oxygen
species are continuously produced in the human body and
in food systems (29). Antioxidants are needed for practical
applications. Although various antioxidants have been
reported, the safety and long-term effects on health of
synthetic antioxidants are to be confirmed. Antioxidants
from natural sources are likely to be more desirable.
Besides the long history of consumption, which proves
the safety of consuming lactic acid bacteria, they have
been reported to have health-promoting characteristics
that make these microorganisms desirable for use in the
production of various health and functional foods.
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